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Abstract
Background: When non-operative management fails to improve symptoms in patients with non-insertional Achilles tendinopathy, surgery may
be required. Various open and endoscopic techniques have been proposed, and platelet-rich plasma (PRP) injections have been proposed as an
adjunct to aid tendon healing.
Methods: Thirty-six patients with mid-portion Achilles tendinopathy were randomized to undergo endoscopic debridement alone (n = 19) or in
combination with intraoperative PRP application (n = 17). Clinical outcome measures included the Visual Analogue Scale for pain, function,
and satisfaction and the Victorian Institute of Sports Assessment  Achilles (VISA-A) questionnaire. Patients were followed-up at 6 weeks, 3
months, 6 months, and 12 months after surgery. An MRI examination at 3 and 12 months was used to assess signal alterations within the tendon.
Results: Both groups showed significant clinical improvement (p < 0.05) after surgery, with no difference between the 2 groups. Tendon diame-
ter increased at 3 months and decreased at 12 months. The tendinopathy area increased at 3 months and decreased at 12 months below baseline
level in both groups. There was no significant difference between the groups regarding the MRI parameters. Nodular thickening and MRI-
detected signal alteration persisted after surgery, with no association between imaging and clinical outcome. Five minor complications were
reported: 2 in the PRP group and 3 in the control group.
Conclusion: Endoscopic debridement of the Achilles tendon improved clinical outcomes in patients with mid-portion tendinopathy. The addition
of PRP did not improve outcomes compared to debridement alone. MRI parameters showed no association with clinical outcomes.
Keywords: Achilles tendon; Endoscopic; Non-insertional; PRP; Tendinopathy1. Introduction
Tendinopathy of the main body of the Achilles tendon is
common and commonly affects elite and recreational ath-
letes.1-6 Achilles tendinopathy (AT) is considered a result of
tendon overuse combined with a failed healing response. Hap-
hazard proliferation of tenocytes, with disruption of collagen
fibers and subsequent increase in non-collagenous matrix, are
observed.7 The role of inflammation is unclear and debatable;
however, recent evidence, based on tendon biopsies in patientsPeer review under responsibility of Shanghai University of Sport.
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that signs of “complex” chronic inflammation are expressed in
tendinopathic cells.8 AT can be disabling, causing pain, stiff-
ness and loss of function.7 The exact origin of symptoms is
uncertain. Adhesions between tendon and paratendinous tis-
sue, with concomitant inflammation (paratendinopathy), may
be one of the sources of symptoms.9-11 The presence of neo-
vascularization12-13 on the ventral aspect into the tendon14-17
has been associated with pain.18,19 A decreased level of the
neoinnervation that accompanies the neovessels has been asso-
ciated with clinical improvement.19 The issue of pain genera-
tion associated with AT is, however, controversial,20 whilst
histological studies indicate that tendinopathy is a risk factorchilles tendinopathy with and without platelet-rich plasma, Journal of Sport and Health
Fig. 1. Flow diagram of patients’ induction into the study.
Table 1
Patient demographics (mean § SD or frequencies).
Variable CON (n = 19) PRP (n = 17) p
Age (year) 43.2 § 11.7 52.8 § 9.8 0.012
Sex
Male 14 14 0.532
Female 5 3
Operated side
Right 8 9 0.516
Left 11 8
BMI (kg/m2) 27.7 § 4.2 26.0 § 3.4 0.203
Abbreviations: BMI = body mass index; CON = control group; PRP = platelet-
rich plasma.
ARTICLE IN PRESS
2 H. Thermann et al.for Achilles tendon rupture.4,9,11,21,22 Non-operative manage-
ment includes rest, local ice therapy, eccentric calf muscle
exercises, extracorporeal shockwave therapy, and peritendi-
nous injections. Eccentric exercises are a mainstay of manage-
ment, and this has also been combined with shock-wave
therapy and application of platelet-rich plasma (PRP) into the
tendinopathic areas.23,24 Although some have advocated the
use of PRP, a recent systematic review of the literature and
meta-analysis, which included 5 randomised controlled trials,
showed that PRP was more effective than placebo in pain
reduction at 6 weeks but not thereafter. The evidence was
deemed limited for definitive conclusions to be drawn.25 In
approximately 25%45% of patients, conservative manage-
ment is not effective, and surgery may be required.9,10,26 One
of the surgical options is excision of the tendinopathic tissue
within the tendon and release of the paratendinous tissue. This
is supposed to result in elimination of the pain-inducing nerve
fibers originating from the Kager fat pad; these fibers are located
on the ventral aspect of the Achilles tendon. Open surgery
results in complication rates of 4.7%11.6%, with infections
and delayed wound healing being the most common,6,27-31 and
minimally invasive endoscopic debridement of the Achilles ten-
don may help to avoid wound-healing problems.
The combination of PRP with endoscopic debridement
could enhance tendon healing. In this way, pain-causing nerve
endings are removed endoscopically, and tendon healing can
be improved with the application of PRP. Furthermore, with
endoscopy, direct visualisation of the tendon allows PRP to be
injected precisely into the tendinopathic areas. In the present
pilot study, we wished to test the hypothesis that endoscopic
debridement of the Achilles tendon coupled with intraopera-
tive application of PRP is more effective than endoscopic
debridement alone in improving functional outcomes in




We performed a prospective randomized controlled trial of
36 consecutive patients in 2018. We included patients in
whom a clinical diagnosis of mid-portion AT had been con-
firmed by magnetic resonance imaging (MRI), and conserva-
tive management for at least 6 months had been unsuccessful.
Exclusion criteria were: presence of a systemic illness, being
below 18 years of age or above 70 years of age, other musculo-
skeletal injuries, previous PRP treatment, and use of fluoroqui-
nolones (Fig. 1).
The study participants were recruited at the Center for
Knee, Foot and Hip Surgery, Heidelberg, Germany. All
patients were secondary referrals to, and were operated on by,
the first author. All patients followed the same standardized
rehabilitation protocol. To assess the effect of additional PRP
injection, the patients were preoperatively and blindly assigned
to one of 2 groups. The control group (CON) included patients
who underwent endoscopic debridement of the main body of
the Achilles tendon only. The study group (PRP) includedPlease cite this article as: Hajo Thermann et al., Endoscopic debridement for non-insertional A
Science (2020), https://doi.org/10.1016/j.jshs.2020.06.012patients who underwent endoscopic debridement and addi-
tional intraoperative application of PRP (Table 1). The trial
was approved by the Ethics Committee of the Faculty of Medi-
cine of the University of Hannover review board (#5883), and
all participants signed written informed consent to participate
in the study.2.2. Randomization procedure
For the purposes of this pilot study, no formal power analy-
sis was performed. Patients were randomized preoperatively to
one of 2 groups: one receiving endoscopic debridement alone,
and the other receiving endoscopic debridement in combina-
tion with PRP. We used a random numbers table to allocate
subjects. Starting with an arbitrary point in the table, we
selected 40 sequential random numbers. The first 20 numbers
were assigned to the endoscopic debridement alone, and the
next 20 numbers were assigned to the endoscopic debridement
in combination with PRP. Patients were blinded regarding thechilles tendinopathy with and without platelet-rich plasma, Journal of Sport and Health
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Achilles tendinoscopy and PRP 3use of PRP. These assignments were then arranged in ascend-
ing order. This procedure produced a random sequence of con-
secutive treatment allocations.2.3. Surgical technique
The surgical procedure has been previously described.32
With the patient in the prone position and under general
anesthesia, the ankles were positioned beyond the edge of
the operating table to allow full range of motion during the
procedure. Two medial portals were produced through
0.5 cm stab wounds just adjacent to the Achilles tendon. The
proximal portal lay 1012 cm proximally to the calcaneal
tuberosity near the musculo-tendinous junction and was used
as the viewing portal, through which a standard 4.5 mm
arthroscope was introduced in a proximal-to-distal direction.
The distal portal was produced just above the calcaneal
tuberosity and was used as the working portal through which
a 4.5 mm full radius shaver was initially introduced pointing
proximal. After the superficial skin incisions had been pro-
duced, the subcutaneous tissues dorsally and ventrally to the
Achilles tendon were separated by blunt dissection with a
mosquito clamp to produce an adequate working space for
the arthroscope and the shaver. The Kager space, ventral to
the Achilles tendon, was irrigated with normal saline. The
whole length of the ventral aspect of the Achilles tendon
could then be inspected and released completely from the
Kager fat using the shaver. The whole length of the Achilles
tendon could be visualized and addressed accordingly. Lon-
gitudinal tenotomies were performed by 2 parallel longitudi-
nal incisions along the tendon using a retrograde knife
blade, according to the MRI images depicting the site of the
lesion (medially, ventrally, or dorsally). Accurate hemostasis
was performed using the OPES (Arthrex, Naples, Florida,
USA) aspirating ablator.
A blood sample (10 mL) to prepare the PRP was taken dur-
ing the operation by a dual lumen syringe (Arthrex). To sepa-
rate the phases, centrifugation was performed for 5 min at
1500 rpm with a Rotofix 32 A centrifuge (Andreas Hettich,
Tuttlingen, Germany). The PRP was applied in the study group
after the endoscopic debridement had been performed by
injecting it under direct endoscopic visualisation in and around
the area of tendinopathy. The endoscopy wounds were closed
with a single stitch with nonabsorbable monofilament, and a
routine bandage was applied.2.4. Rehabilitation
Postoperatively, foot elevation was encouraged, oral anal-
gesia was administered as required, and patients were
encouraged to perform active ankle dorsal and plantar flex-
ion. Mobilisation with crutches and partial weight bearing
was allowed on the 1st postoperative day. Full weight bear-
ing was started after removal of sutures around the 14th
postoperative day. Proprioceptive training and physical
activities with increased loading on the Achilles tendon,
such cycling or cross training, were allowed starting at thePlease cite this article as: Hajo Thermann et al., Endoscopic debridement for non-insertional A
Science (2020), https://doi.org/10.1016/j.jshs.2020.06.012third week. Running and sport-specific training was allowed
after 3 months.
2.5. Outcome assessment
For the purposes of the present study, an orthopaedic fellow
who was independent from the surgeon assessed all patients
before surgery and after 6 weeks, 3 months, 6 months, and 12
months. Outcome assessment consisted of data collection at
each visit, using:
 Achivisual analog scale (VAS) for pain, function, and satis-
faction.
 A VISA-A questionnaire (Victorian Institute of Sports
Assessment  Achilles)33 at each time-point except directly
postoperative. An MRI, preoperatively, at 3 months, and at 12 months.
The MRI included a T1w sagittal spin echo (SE) sequence,
T1w axial SE sequence, T1w axial turbo 3D gradient echo
(GE) sequence and sagittal short-tau inversion recovery
(STIR) sequence. Sagittal axes were placed along the longi-
tudinal axis of the Achilles tendon in a coronal scout view.
The axial plane was placed in a vertical axis to the sagittal
axis. The thickness of the T1w sagittal SE sequence was
2.5 mm, with a gap of 0.3 mm. The thickness of the T1w
axial SE sequence was 4.0 mm, with a gap of 0.4 mm. The
thickness of the sagittal STIR sequence was 2.5 mm with a
gap of 0.2 mm. The images were taken with a 0.3 T imager
(O-scan, Esaote, Italy).313. Results
Over the calendar year of the study, 36 patients were
recruited and randomized. The mean age was significantly dif-
ferent between the 2 groups, whereas gender distribution,
treated side, and body mass index were similar (Table 1).
Five minor complications were recorded (13.8%). Two
patients (one in each group) developed a superficial infection,
and 2 patients (one in each group) reported slight hypoesthesia,
one of which also had hematoma formation.
VAS scores for pain, function, and patients’ satisfaction in
the entire patient cohort (n = 36), improved significantly (p 
0.001) during all follow-up visits, compared to preoperative
(baseline) values. VISA-A showed no significant change at 6
weeks after surgery (p = 0.194), compared to baseline, but was
significantly better than at baseline (p  0.001) at 3 months, 6
months, and 12 months after surgery.
For the entire patient cohort (n = 36), the tendon cross-sec-
tion (axial) area, as determined by the MRI, increased insignif-
icantly (p = 0.07) at 3 months and decreased to a level above
baseline by 12 months after surgery (p = 0.15) (Fig. 2). Maxi-
mum tendon diameter moved cranially over time, with high
significance in the postoperative examinations. The longitudi-
nal extension of the area of altered tendinopathic signal
increased slightly after 3 months (p = 0.24) and subsequently
declined significantly by 12 months after surgery (p = 0.004)
(Fig. 3).lles tendinopathy with and without platelet-rich plasma, Journal of Sport and Health
Fig. 2. Tendon axial area, measured by magnetic resonance imaging. Mean
values with standard deviation, preoperatively (baseline) and postoperatively
at 3 and 12 months. Data are presented as mean § SD or SE?
Table 2
Clinical outcome parameters (mean § SD).
CON PRP p
VAS-pain
Baseline 64.4 § 20.5 53.8 § 25.6 0.179
6 weeks 32.2 § 23.9 18.3 § 20.6 0.071
3 months 15.4 § 24.0 16.4 § 18.8 0.892
6 months 13.8 § 20.4 8.8 § 8.8 0.354
12 months 9.0 § 13.1 4.5 § 5.4 0.199
VAS-function
Baseline 28.0 § 21.7 41.5 § 19.3 0.058
6 weeks 54.1 § 23.5 67.8 § 14.6 0.042
3 months 66.4 § 21.7 81.1 § 11.1 0.015
6 months 78.4 § 24.5 89.3 § 8.8 0.084
12 months 86.0 § 18.9 95.6 § 4.9 0.045
VAS-satisfaction
Baseline 17.3 § 25.2 28.9 § 27.6 0.194
6 weeks 44.6 § 31.6 72.9 § 19.3 0.003*
3 months 61.7 § 25.6 78.0 § 16.8 0.030*
6 months 74.2 § 26.1 82.1 § 13.1 0.254
12 months 85.1 § 21.5 90.2 § 9.6 0.356
VISA-A
Baseline 42.6 § 17.9 43.4 § 22.5 0.916
6 weeks 51.6 § 11.6 45.1 § 19.2 0.240
3 months 73.4 § 12.1 71.3 § 18.6 0.691
6 months 79.6 § 14.1 83.1 § 11.7 0.421
12 months 89.5 § 10.7 92.2 § 8.2 0.396
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no difference between the 2 groups at any pre- or postoperative
examination (Table 2). VAS-satisfaction was significantly bet-
ter in the PRP group at 6 weeks and 3 months but showed no
difference, compared to the control group, at 6 and 12 months
(Table 2). The VISA-A score showed no significant differen-
ces between the groups at any point of time (Table 2). None of
the MRI parameters showed significant differences between
the groups (Table 3).
* p < 0.05, significantly different compared to baseline.
Abbreviations: CON = control group (endoscopic debridement only);
PRP = group receiving platelet rich plasma injection; VAS = visual analogue
scale; VISA-A = Victorian Institute of Sports AssessmentAchilles.
Table 3
Tendon thickness and tendinopathic area variation in the 2 groups (mean §
SD).
CON PRP p
Tendon axial area4. Discussion
The present study confirmed that endoscopic debridement
of the Achilles tendon led to clinical improvement in our 36
patients who had mid-portion AT and who had failed previous
non-operative management. No major complications were
observed. However, the additional intraoperative injections of
PRP did not exert any detectable influence on the outcome of
the procedure. Imaging findings were not associated with clini-
cal outcome scores. Our findings are consistent with the few
published studies from other institutions.
To our knowledge, only 3 studies have been previously
published concerning endoscopic procedures for midportion
AT.33-35 They reported major complication rates between 0%
and 7.4%. Procedures included debridement of the paratenon,
and an additional release of the plantaris tendon was per-
formed in 2 studies and longitudinal tenotomies in 1. The stud-
ies showed good results regarding functional outcome and
postoperative pain. Only 1 study explicitly mentioned the
release of the ventral aspect of the Achilles tendon, where theFig. 3. Measure on magnetic resonance imaging. Mean values, with standard
deviation, of the entire patients’ cohort (n = 36), preoperatively (baseline) and
postoperatively at 3 and 12 months.
Please cite this article as: Hajo Thermann et al., Endoscopic debridement for non-insertional A
Science (2020), https://doi.org/10.1016/j.jshs.2020.06.012neovessels are located.36 Postoperative care consisted of
weight bearing as tolerated and active range of motion of the
ankle in 2 studies,35,36 whilst 1 study (Maquirriain et al.34)
adopted a progressive postoperative rehabilitation protocol,
using a walker boot until the 4th week and allowing jogging
during the 3rd month.32
In other studies, PRP injections showed promising results as
part of the nonoperative management of tendinopathies.37-39
Monto38 reported on 30 patients who had failed conventionalBaseline 1.34 § 0.57 1.58 § 0.59 0.281
3 months 1.66 § 0.65 1.82 § 0.94 0.592
12 months 1.57 § 0.60 1.64 § 0.64 0.780
Signal alteration axial area
Baseline 0.74 § 0.59 0.79 § 0.50 0.842
3 months 0.89 § 0.60 0.85 § 0.74 0.851
12 months 0.53 § 0.37 0.30 § 0.29 0.106
Cranio-caudal signal alternation distance
Baseline 4.12 § 2.01 3.43 § 1.70 0.334
3 months 3.59 § 1.95 4.00 § 1.68 0.571
12 months 2.03 § 1.63 1.62 § 1.28 0.497
Abbreviations: CON = control group (endoscopic debridement only);
PRP = group receiving platelet rich plasma injection.
chilles tendinopathy with and without platelet-rich plasma, Journal of Sport and Health
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Achilles tendinoscopy and PRP 5conservative therapy for AT and had received PRP monother-
apy. At the end of the study, 28 of the 30 patients showed
American Orthopaedic Foot & Ankle Society score improve-
ment from 34 points prior to the injection to 88 points 1 year
later.38 Owens et al.39 found moderate improvement on the
Foot and Ankle Ability Measure scores, which increased from
55.4 to 65.8, Foot and Ankle Ability Measure-Sports scores
(FAAMS) which increased from 14.8 to 17.4, and Short Form
Health Survey scores (SF-8), which increased from 24.9 to
30.0 2 years postintervention. MRI results did not show quali-
tative improvements in the appearance of the tendon. Both
studies were case series, with no control groups. On the other
hand, a randomised controlled study combining injections
therapy (PRP vs. normal saline) with an eccentric exercise pro-
gram found no significant difference in clinical outcomes
(VISA-A) after 1 year23 and no difference in the sonographic
appearance of the tendons.40 In our study, despite the high sen-
sitivity of 94%, the specificity of 81%, and a positive predic-
tive value of 90% of MRI scanning, there was no association
between tendon appearance and function.
We point out that the patients in the PRP group exhibited a
slightly better postoperative function, but these patients had a
slightly higher VAS-function score prior to surgery (Table 2).
In addition, patients’ satisfaction was slightly better in the
PRP group at 6 weeks and 3 months after surgery but was simi-
lar to the level of the control group’s satisfaction thereafter
(Table 2). Given our small sample size, these differences can-
not lead to definite conclusions. MRI findings showed that, fol-
lowing surgery, the size of the tendon increased at 3 months
and decreased thereafter. The remarkable heterogeneity of the
MRI results, in combination with the small sample size, does
not allow correlation with clinical outcomes.
The present investigation is a pilot study, and the small
sample size in each group obviously could be a source of
experimental error. However, in our setting, AT is not often
treated operatively, and we used strict inclusion criteria.
Hence, the recruitment of a larger number of patients would
require a long period of time. On the other hand, our study was
a randomized comparative study, where the investigator was
blinded to the treatment the patients had received, and all sur-
geries were performed by the same experienced surgeon. It
should be noted that despite the randomization of patients in
the 2 treatment groups in our study, patients in the PRP group
were significantly (almost 10 years) older than in the non-PRP
(control) group. It is uncertain whether this parameter influ-
enced the results, as younger patients may have better healing
potential.41 The main finding in our study was that, for the 36
patients in whom a well-described standard surgical technique
was used, endoscopic debridement of the noninsertional (ten-
dinopathic) portion of the Achilles tendon resulted in signifi-
cant clinical improvement. In the present study, the addition of
PRP did not exert any significant effect.5. Conclusion
In our study, endoscopic debridement for tendinopathy of
the main body of the Achilles tendon was effective and had aPlease cite this article as: Hajo Thermann et al., Endoscopic debridement for non-insertional A
Science (2020), https://doi.org/10.1016/j.jshs.2020.06.012low complication rate, but PRP injection did not improve clini-
cal outcomes, and tendon abnormalities revealed by postopera-
tive MRI scanning did not correlate with clinical or functional
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